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Epigallocatechin-3-O-gallate (EGCG), the major polyphenolic compound present in green tea, 
has potent antioxidant and free radical scavenging activities. In this study, various 
concentrations (10, 100 and 1000 ppm) of EGCG were incorporated into a collagen sponge 
(CS) in order to investigate its healing effects on full thickness wounds created in type 2 
diabetic mice. After 14 d, the residual wound size of the mice treated with 10 ppm 
EGCG-incorporated collagen sponge (E-CS) decreased significantly faster than that of the 
other mice. Moreover, significant increases in the degree of re-epithelialization, the thickness 
of the granulation tissue and the density of the capillaries were also histologically observed in 
the wound sites exposed to 10 ppm E-CS in comparison to the others. Furthermore, 10 ppm 
E-CS resulted in significant increases in the immunoreactivity of Ki-67 (re-epithelialization 
at wound site), CD31 (formation of blood vessels) and α-smooth muscle actin (the induction 
of myofibroblasts across the dermis). These results suggest that a CS incorporated with 
EGCG at low concentrations can enhance wound healing in diabetic mice by accelerating 
re-epithelialization and angiogenesis as well as improving the cellular reorganization of 




Wound healing is a complex multifactorial process involving the interaction of 
inflammation, re-epithelialization, angiogenesis, granulation tissue formation and collagen 
deposition. The wound healing process is associated with extensive oxidative stress to the 
system, which generally inhibits tissue remodeling. Epigallocatechin-3-O-gallate (EGCG), 
the predominant catechin from tea, possesses much stronger anti-oxidant activities than 
vitamin C by virtue of its peculiar stereo chemical structure and it has also been shown to 
play an important role in preventing cancer and cardiovascular diseases (1). Moreover, it also 
has other beneficial effects, including anti-inflammatory, antimicrobial and 
immunomodulatory activities (2). EGCG was also found to exert differential activities on 
normal epidermal keratinocytes vs. epidermoid carcinoma (A431) cells (3) and to induce the 
differentiation and proliferation of normal epidermal keratinocytes. These results suggest that 
EGCG can be used for the treatment of dermal wounds by means of facilitating 
re-epithelialization during the wound healing process (4). 
Chronic wound healing is a troublesome and common complication of diabetes resulting 
in significant clinical morbidity. Genetically, diabetic mice are useful as an animal model for 
wound-healing studies, since wound healing in these animals is markedly delayed in 
comparison to nondiabetic littermates (5). Healing impairment is characterized by delayed 
cellular infiltration and granulation tissue formation, reduced angiogenesis and decreased 
collagen organization. The mechanism of this alteration is thought to result from the diabetic 
production of reactive free radicals that cause lipid peroxidation, which in turn impairs the 
activity of keratinocytes, endothelial cells and fibroblasts. 
Collagen sponges (CSs) were transplanted to full thickness wounds to mimic the 
treatment of deep wounds in patients as closely as possible. The CS matrix promotes the 
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migration of host cells and blood vessels into the structure, thus allowing rapid replacement 
by host tissue at the wound site and finally helping to form dermis-like granulation tissue. 
However, the application of a CS only is limited to chronic wounds because the CS can easily 
degrade due to the lowered immunity of diabetic mice against microbial infection (5). This 
bacterial contamination triggers not only the degradation of the CS by collagenase produced 
from the bacteria, but also bacterial growth in the degraded CS (6). Therefore, it is necessary 
to improve the CS to overcome these problems. In this study, the wound healing effects of 
EGCG-incorporated collagen sponges (E-CSs) were investigated on full thickness wounds in 
type 2 diabetic mice. To evaluate the effects of E-CS, re-epithelialization, granulation, 
angiogenesis and myofibroblast induction were histologically or immunohistochemically 
examined at the wound sites. Since EGCG has a beneficial effect under high glucose diabetic 
conditions (7) and it also stabilizes collagen (8), EGCG may therefore be potentially used as a 
healing and supportive agent in diabetic wound healing utilizing a collagen-based artificial 
dermis. 
 




Genetically diabetic male BKS.Cg-+ Leprdb/ +Leprdb/JCL mice were obtained from Slc 
Japan Inc. (Osaka, Japan). All mice were maintained on a standard laboratory diet and water 
ad libitum and experimentally used when aged 10 wk old at the time of wounding. Each 
mouse was housed individually. Animal care followed the criteria of the Animal Care 
Committee of Institute for Frontier Medical Sciences, Kyoto University for the care and use 
of laboratory animals in research. 
4 
 
E-CS preparation and surgical procedures for wounding 
 
E-CSs were prepared by treating CSs (Pelnac®, Gunze Co., Kyoto, Japan) with various 
concentrations (10, 100 and 1000 ppm) of EGCG (Teavigo™, DSM Nutritional Products Ltd., 
Basel, Switzerland) overnight at 4°C. The diabetic mice were anesthetized with 
intraperitoneal pentobarbital (30 mg/kg, Nembutal, Abbott Laboratories, North Chicago, IL). 
Under sterile conditions, the dorsal area was totally depilated and a single full thickness 
excisional square wound (1 × 1 cm2) was created on the upper back of each mouse using a 
pair of sharp scissors and a scalpel. Either CSs or various concentrations of E-CSs were 
transplanted into the wounds of the mice. In order to observe the direct effect of EGCG on 
wound healing, the mice topically received 0.1 ml of EGCG (10, 100 and 1000 ppm, 
respectively) or vehicle (saline) solution once a day for 3 d after wounding. After 7 and 14 d 
of the transplantation of CS or E-CSs, the mice were euthanized using pentobarbital 
anesthesia. All experiments related to surgical procedures and treatments were performed in 
accordance with the guidelines of the Animal Experiment Committee of Institute for Frontier 
Medical Sciences, Kyoto University. 
 
Determination of residual wound area 
 
In order to determine EGCG-mediated healing efficiency, the residual wound size was 
measured from the unclosed wound area after 7 and 14 d of transplantation using a digital 
planimeter (PLACOM KP-90N, Koizumi Sokki Mfg. Co. Ltd., Nagoya, Japan). After wound 
size measurement at 7 and 14 d, the wounded tissues were excised in full depth and bisected. 
The tissues were fixed in 10% formaldehyde and then embedded in paraffin for the 
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histological and immunohistochemical evaluations as mentioned below. 
 
Histological and immunohistochemical analyses 
 
Paraffin-embedded tissue blocks were sectioned by a 5 µm thickness and then stained 
with hematoxylin and eosin (H&E). The sections were also stained with rabbit polyclonal 
antibody Ki-67 (Novocastra, Newcastle, UK), mouse monoclonal antibody α-smooth muscle 
actin (α-SMA, clone 1A4, Dakocytomation, Inc., Carpinteria, CA) and mouse monoclonal 
antibody CD31 (PECAM-1, Novocastra). To immunohistochemically examine the expression 
of Ki-67 and CD31 in the excisional wound tissue, the sections were pretreated in 10 mM 
citric acid buffer (pH 6.4) at 121°C for 20 min and then washed with PBS. To block 
endogenous peroxidase, all sections were immersed in 10% H2O2 in methanol for 10 min and 
then washed with PBS for 5 min. To determine myofibroblasts, α-SMA was detected by 
incubating dewaxed sections first in 10% rabbit serum for 30 min, followed by mouse 
anti-human α-SMA antibody at 4°C overnight. The bound antibody was detected by 
biotinylated rabbit anti-mouse antibody and streptavidin–HRP–DAB. Negative controls were 
generated by incubating slides with immunoglobulin from the same species and at the same 
final concentration, but with no primary antibody. The prepared sections were all observed 
under an optical/fluorescence microscope (Biozero – 8000, Keyence, Osaka, Japan). 
 
Histomorphometric and quantitative analyses 
 
The H&E-stained sections as prepared above were histomorphometrically examined for 
the epithelial regeneration and organization of granulation tissues. For measuring the length 
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of re-epithelialization, the wound edges were determined as the border between the original 
dermis with hair follicles and the newly developed fibrotic dermis without hair follicles. The 
thickness of granulation tissue was determined, at the center of each section, from the surface 
of granulation tissue to the margin of dermis and subcutis, vertically. 
To determine the number of capillary and immuno-reactive cells, the stained wound 
sections were observed under × 200 magnifications with a test grid eyepiece. The number of 
Ki-67 positive cells at the basement membrane of epidermis was counted in both wound 
margin areas (300 × 300 µm2 in dimension). The number of α-SMA and CD31 positive cells 
was measured in three different areas (× 200 magnifications) at both ends as well as in the 
middle of dermis. These quantitative counts were made independently by two observers 
blinded to treatment, and the counts were compared to ascertain that no more than 10% 




All variables were tested in four independent experiments, and each experiment was 
repeated three times (n = 10-12). Quantitative data were expressed as mean ± standard error. 
Statistical comparisons were carried out with an analysis of variance (ANOVA, SAS Institute 
Inc., Cary, NC), which was followed by the Fisher’s PLSD test using StatView-J 4.5 software 





Effect of E-CS on the cutaneous wound healing in diabetic mice 
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Figure 1 shows the appearance of the wounds after 7 and 14 d of treatment. After 7 d, 
the connective tissues were observed to have slightly regenerated with some local infection. 
However, at 14 d 10 ppm E-CS treatment resulted in an appreciable improvement in the 
wound closure in comparison to that observed with the CS only (control) and other 
concentrations of E-CSs. In addition, the wounds treated with 10 ppm E-CS decreased in size 
without oozing. The residual wound area was also determined by measuring the unclosed 
wound area as a function of time (Fig. 2). The wounds began to close after 10 d and the 
residual wound sizes significantly decreased in all groups after 14 d. Importantly, the wounds 
treated with 10 ppm E-CS showed the smallest residual wound area. In contrast, the mice 
treated with 1000 ppm E-CS showed impaired wound closure. The residual wound area in the 
CS treated group was intermediate which is similar to the wound size of the 100 ppm E-CS 
treated group. 
 
Effect of E-CS on re-epithelialization and granulation formation 
 
To examine the effects of EGCG on epithelial and dermal regeneration, the length of 
re-epithelialization and the thickness of the granulation tissue were determined, respectively. 
Figure 3A shows the length of the regenerated epidermis in the wounds treated with CS or 
various concentrations of E-CSs. There was no significant difference in the epithelial 
regeneration between the wounds treated with CS and E-CSs at 7 d (Fig. 3B). However, the 
re-epithelialization significantly (p < 0.05) increased in the wounds treated with 10 ppm 
E-CS after 14 d. These results were consistent with those of the residual wound area. 
Moreover, 10 ppm of E-CS treatment resulted in a significant (p < 0.05) enhancement in the 
granulation tissue formation (Fig. 4). However, after 7 d of treatment, no significant 
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difference was observed in the granulation tissue formation between the wounds transplanted 
with CS and E-CSs (Data not shown). The wounds treated with 10 ppm E-CS showed a 
well-regenerated and differentiated epidermis, relatively higher cell number and significantly 
thick dermis, whereas those treated with CS showed early on-going epithelialization, evident 
edema and poorly formed granulation tissue (Fig. 3A and 4A). Furthermore, it was also 
revealed that 10 ppm E-CS induced an increase in the epithelial migration with a concomitant 
decrease in the wound gap and width after 14 d of transplantation. These results indicate that 
the 10 ppm E-CS treatment significantly accelerates the epithelial and dermal regeneration of 
the diabetic wound site 
 
Immunohistochemical analysis of the effect of E-CS on wound healing 
 
Figure 5 shows the representative immunolocalization of Ki-67, α-SMA and CD31 in 
the wounds treated with CS or E-CSs after 14 d. Ki-67-positive cells were mainly observed at 
the basal layer of the epidermis (Fig. 5A). The strongest positive staining for Ki-67 was 
shown in the wounds treated with 10 ppm E-CS after 14 d; thus leading to significantly (p < 
0.05) more newly formed epidermis with a thicker layer of the basal membrane. This result 
implies that re-epithelialization in the wounds treated with 10 ppm E-CS was enhanced by 
increased proliferation of basal epidermal keratinocytes. It was also found that the number of 
cells positive for Ki-67 in the 10 ppm E-CS treated group was significantly (p < 0.05) higher 
than that in the others (Fig. 5B).  
α-SMA-positive myofibroblasts across the dermis were mainly observed at the bottom 
of granulation tissue as shown in Figure 5A. It was revealed that treatment with 10 ppm 
E-CS resulted in significant (p < 0.05) increase in the number of cells expressing α-SMA 
after 14 d (Fig. 5B). However, the other wounds treated with 100 or 1000 ppm E-CS showed 
9 
fewer α-SMA-positive stained cells than for the CS transplantation. 
The wounds treated with 10 ppm E-CS showed the greatest positive staining for CD31 
and significantly (p < 0.05) more newly generated capillaries, which were diffusely located 
and clearly formed tube-like structures (Fig. 5A). The size of vessels in the 10 ppm E-CS 
treated wounds was much bigger than that in the others. On the other hand, the 
CD31-positive stained capillaries in 100 or 1000 ppm E-CS treated wounds were almost 
identical to those in the CS treated group. There was no significant difference among them; 
however, the capillary formation was slightly enhanced in the wounds treated with 1000 ppm 




Kapoor et al. demonstrated that epicatechin gallate (ECG), one of the catechin 
components in green tea, could significantly improve the quality of wound healing and scar 
formation in an incisional wound healing model in rats (9). These reports led us to investigate 
the effect of CSs incorporated with EGCG on chronic wound healing. Although EGCG is 
considered to be a potentially effective wound-healing agent with a wide range of 
pharmacological and biological activities, relatively little is known about the precise 
mechanisms of the wound-healing effect of EGCG in vivo. 
Clinically, it is important to reduce the wound area as fast as possible in order to alleviate 
stress as well as reduce the possibility of infection and dehydration (10). In addition, the 
measurement of the residual wound size is a simple and frequently utilized way to analyze 
the efficiency of any treatment on wound healing. As shown in Figures 1 and 2, 10 ppm 
E-CS treatment accelerated wound size reduction in comparison to the control and other 
groups. This was associated with both accelerated re-epithelialization and contraction (Fig. 3). 
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Epithelialization is achieved by the proliferation and migration of epidermal cells from the 
wound edge. Wound contraction is based on a full-thickness afferent shift (11) and it 
favorably accelerates wound healing, but it can also sometimes cause a functional disturbance. 
Therefore, an appropriate balance of epithelialization and wound contraction is required for 
this region.  
EGCG has been shown to stimulate the proliferation and differentiation of keratinocytes 
(4). Keratinocytes are the major cell type of the epidermis and they play an important role in 
epidermal construction (12). The basal epidermal layer contains keratinocyte stem cells that 
replenish the epidermis (12). Ki-67 is a nuclear protein that is expressed in proliferating cells 
and widely used as a proliferation marker (13). In the present study, 10 ppm E-CS treatment 
significantly accelerated re-epithelialization via the proliferation of basal epidermal 
keratinocytes, which was demonstrated by Ki-67 immunostaining (Fig. 5A).  
Wound size reduction in the wounds treated with 10 ppm E-CS was also confirmed by an 
appreciable enhancement in the number of α-SMA expressing myofibroblasts in the dermis 
(Fig. 5). During granulation tissue formation, fibroblasts differentiate into myofibroblasts 
(14). The new connective tissue is synthesized by myofibroblasts, fibroblasts capable of 
migrating and characterized by the presence of contractile features due to their intermediate 
morphology between that of a fibroblast and a smooth muscle cell. The presence of 
myofibroblasts is considered to be characteristic of tissue undergoing contraction (15, 16). 
The apparent greater number of myofibroblasts in the 10 ppm E-CS treated group may be 
partially responsible for the fast wound contraction. Therefore, it is suggested that the 
reduction of wound size in 10 ppm E-CS treated group might be attributed to the coordination 
of re-epithelialization and contraction mediated by increased activation of epidermal 
keratinocytes and myofibroblasts, respectively. Therefore, these results show that a collagen 
sponge incorporating 10 ppm of EGCG is therefore promising for future clinical application. 
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The fact that wound reduction observed in the E-CS treated group at 7 d was poor in 
comparison to that on day 14 may be partially explained by EGCG having a potent mitogenic 
and chemoattractive effect of EGCG on endothelial cells and fibroblasts. In other words, 
EGCG is likely to mainly promote the second half of the wound healing process, including 
granulation, angiogenesis and re-epithelialization, which is therefore an important factor in 
wound reduction. In fact, in the present study, granulation, vascularization and 
epithelialization were all significantly accelerated by 10 ppm E-CS treatment on day 14. 
Figure 4 indicates thick granulation tissue with both fibrous tissues and cellular components 
to be closely related to re-epithelialization, angiogenesis and wound reduction. In addition, 
the enhanced capillary formation and re-epithelialization were confirmed by an 
immunohistochemical analysis (Fig. 5). 
In contrast, treatment with 1000 ppm E-CS did not enhance re-epithelialization (Fig. 1-3). 
The topical and repeated exposure to EGCG could thus lead to dermal sensitivity and minor 
irritation (17). The impaired healing observed in the 1000 ppm E-CS treated group could be 
the result of the toxicity of EGCG when administered at high doses.  
The data are not shown but the LD50 value of EGCG was investigated in various cell 
types. Human microvascular endothelial cells were highly sensitive to EGCG. Although the 
species was different from that of the current study, the LD50 value of 70 ppm in endothelial 
cells implies that 100 ppm EGCG treatment might be cytotoxic to endothelial cells and thus 
inhibit angiogenesis.  
Newly formed granulation tissues were found to be substantially thick and well 
developed in the wounds treated with 10 ppm E-CS (Fig. 4). Granulation tissue formation 
was not expected to be induced by application of EGCG because EGCG is reported to inhibit 
fibroblasts migration in vitro (18). However, EGCG treatment with a low dose, i.e.10 ppm, 
was shown to enhance the organization of granulation tissue by stimulating the growth of 
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fibroblasts in the present study. Stimulation of skin fibroblasts can contribute to the 
fibroblast-keratinocyte-endothelium complex that not only repairs wounds, but also maintains 
their integrity. In the highly coordinated biological process of dermal wound healing, skin 
fibroblasts interact with surrounding cells and produce collagen-based extracellular matrices 
which ultimately replace the provisional fibrin-based matrix and accelerate the reduction of 
the wound edges through their contractile properties (15). 
Wound healing is an angiogenesis-dependent process, because oxygen and nutrients are 
required to promote the newly forming granulation tissue. An immunohistochemical analysis 
using the endothelial cell marker, CD31 showed that new capillaries were significantly 
regenerated in wounds treated with 10 ppm E-CS (Fig. 5). During the regeneration process, 
revascularization can increase the resistance to infection (5). In diabetic mice, an inadequate 
blood supply that results from venous insufficiency and cuffing of microvessels are 
contributing factors toward healing impairment. In this study, EGCG was shown to exert a 
potent angiogenic activity in vivo.  
In conclusion, although the mechanism responsible for the acceleration of wound healing 
in diabetic mice is still not completely understood, the results of these experiments 
demonstrate that transplantation of a CS incorporated with a low concentration of EGCG 
induced significant wound contraction, re-epithelialization and angiogenesis as well as the 
reorganization of granulation tissue by triggering the activity of myofibroblasts. 
EGCG has been shown to activate different pathways depending on the cell type while 
functioning differently according to its concentration (19, 20). T. Yamamoto et al. showed 
200 µM (91.6 ppm) of EGCG damaged only tumor cells (oral squamous cell carcinoma, 
OSC-2 and OSC-4) but not normal cells (normal human primary epidermal keratinocytes). 
Chen et al. have reported that exposure to 200 µM (91.6 ppm) EGCG for 8 hr induced less 
than 1% apoptosis in WI38 human fibroblasts. In vitro studies have indicated the mechanism 
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of EGCG activity at the cellular level. However, the wound healing process in vivo is 
complicated and multifactorial and it is hard to elucidate the mechanism of EGCG 
involvement. Although the overall beneficial effects of EGCG in vivo were shown in this 
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Figure 1. Appearance of the wounds in diabetic mice after 7 and 14 d of treatment of 
CSs incorporate without or with various concentrations of EGCG. These photographs 
are representative of 10 independent experiments, showing similar results. 
 
Figure 2. Residual wound size of diabetic mice treated with CS (EGCG 0 ppm) or 
various concentrations of E-CSs. It was measured from the unclosed wound area 
after 7 and 14 d of treatment using a digital planimeter. The results are reported as 
mean ± standard error (n = 10) and analyzed by the Fisher’s PLSD test. The value 
marked with an asterisk is significantly (p < 0.05) different from the control (CS). 
 
Figure 3. Effect of E-CSs on the epithelial regeneration. A) Histological observations 
(× 50) of the regenerated epithelial tissues in the wounds treated with CS or various 
concentrations of E-CSs after 7 and 14 d. Dotted lines indicate the leading edge and 
route of re-epithelialization where an arrow (↑) on the left side of each photograph 
represents the wound edge, and another arrow (↓) on the right side represents the 
end point of re-epithelialization. These photographs are representative of 8 
independent experiments, showing similar results. B) The length of re-epithelialization. 
The results are reported as mean ± standard error (n = 10) and analyzed by the 
Fisher’s PLSD test. The values marked with an asterisk are significantly (p < 0.05) 
different from those after 7 d. The value marked with a sharp is significantly (p < 0.05) 
different from the other groups. 
 
Figure 4. Effect of E-CSs on the formation of granulation tissues. A) Histological 
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observations (× 100) of the newly formed granulation tissues in the wounds treated 
with CS or various concentrations of E-CSs after 14 d. Dotted arrows indicate the 
center of granulation tissues. These photographs are representative of 8 independent 
experiments, showing similar results. B) The thickness of granulation tissue. The 
results are reported as mean ± standard error (n = 10) and analyzed by the Fisher’s 
PLSD test. The value marked with an asterisk is significantly (p < 0.05) different from 
the other groups. The value marked with a sharp is significantly (p < 0.05) different 
from the control (CS). 
 
Figure 5. Effect of E-CSs on the wound healing in diabetic mice. A) 
Immunohistochemical observations (× 200) of the wounds treated with CS or various 
concentrations of E-CSs and stained with anti-Ki-67, anti-α-SMA and anti-CD31 
antibody after 14 d (A scale bar means 100 µm). These photographs are 
representative of 8 independent experiments, showing similar results. B) Quantitative 
analyses of cells showing immunopositivity to Ki-67, α-SMA or CD31. The results are 
reported as mean ± standard error (n = 10) and analyzed by the Fisher’s PLSD test. 
The value marked with an asterisk is significantly (p < 0.05) different from the other 
groups. The value marked with a sharp is significantly (p < 0.05) different from the 
control (CS). 
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